Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ: RCKT · Real-Time Price · USD

3.650

+0.310 (9.28%)

At close: Aug 19, 2026, 4:00 PM EDT

3.620

-0.030 (-0.82%)

Pre-market: Aug 20, 2026, 8:48 AM EDT

Rocket Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	224.51	77.56	163.64	55.9	140.52	232.69
Short-Term Investments	59.24	111.37	208.7	317.27	215.88	156.05
Cash & Short-Term Investments	283.75	188.93	372.34	373.18	356.39	388.74
Cash Growth	4.51%	-49.26%	-0.22%	4.71%	-8.32%	-19.47%
Prepaid Expenses	5.8	3.81	5.85	5.05	7.67	3.32
Total Current Assets	289.55	192.73	378.18	378.22	364.06	392.06
Property, Plant & Equipment	67.42	71.59	83.32	87.59	77.65	72.35
Long-Term Investments	-	-	-	34.32	43.28	-
Goodwill	39.15	39.15	39.15	39.15	39.15	30.82
Other Intangible Assets	25.15	25.15	25.15	25.15	25.72	-
Other Long-Term Assets	1.82	1.82	1.89	1.91	1.95	1.8
Total Assets	423.1	330.45	527.7	566.34	551.81	497.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.35	2.33	1.63	1.77	2.27	0.48
Accrued Expenses	18.37	24.91	36.02	29.8	30.54	17.81
Current Portion of Leases	2.98	2.92	2.86	2.72	2.51	2.55
Current Unearned Revenue	-	-	-	-	0.6	0.6
Other Current Liabilities	-	0.05	0.19	14.21	3.25	0.73
Total Current Liabilities	31.32	30.21	40.68	48.51	39.17	22.17
Long-Term Leases	21.82	21.96	22.64	22.33	20.36	20.05
Other Long-Term Liabilities	1.13	1.06	1.14	2.94	2.6	0.08
Total Liabilities	54.27	53.23	64.47	73.77	62.12	42.3

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1.1	1.08	1.07	0.9	0.79	0.65
Additional Paid-In Capital	1,733	1,717	1,680	1,451	1,203	946.15
Retained Earnings	-1,366	-1,441	-1,218	-959.37	-713.78	-491.91
Treasury Stock	-	-	-	-	-0.05	-
Comprehensive Income & Other	-0.11	-0.03	0.07	0.32	-0.36	-0.16
Total Common Equity	368.83	277.22	463.23	492.57	489.69	454.72
Shareholders' Equity	368.83	277.22	463.23	492.57	489.69	454.72
Total Liabilities & Equity	423.1	330.45	527.7	566.34	551.81	497.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	24.8	24.88	25.5	25.04	22.87	22.6
Net Cash (Debt)	258.95	164.05	346.84	348.13	333.53	366.14
Net Cash Growth	5.14%	-52.70%	-0.37%	4.38%	-8.91%	-13.04%
Net Cash Per Share	2.31	1.48	3.66	4.14	4.89	5.79
Filing Date Shares Outstanding	109.77	108.57	106.63	90.5	79.35	64.51
Total Common Shares Outstanding	109.54	108.32	106.45	90.28	79.12	64.51
Working Capital	258.23	162.53	337.5	329.72	324.89	369.89
Book Value Per Share	3.37	2.56	4.35	5.46	6.19	7.05
Tangible Book Value	304.53	212.92	398.93	428.27	424.81	423.91
Tangible Book Value Per Share	2.78	1.97	3.75	4.74	5.37	6.57
Machinery	48.16	48.06	48.85	44.58	35.61	25.21
Leasehold Improvements	7.33	7.33	7.28	6.72	0.59	0.41

SEC Filings: 10-K · 10-Q